PQS Step 15: Risk Review – GATEWAY CRITERIA

Published: Mon, 11/29/21

PharmaPlus PQS Bitesize Guide Step 15:

29 November 2021

Risk Review – GATEWAY CRITERIA

Dear Member,

So far we have shared:
STEP 1: Returning unwanted inhalers – Email sent on 31/08/2021
STEP 2: NMS expansion and gateway criteria – Email sent on 1/09/2021

STEP 3: Inhaler technique checks as part of the catch up NMS service – Email sent on 10/09/2021
STEP 4: Staff training requirements – Email sent on 14/09/2021
STEP 5: PCN Leads requirements – Event on 27/09/2021

STEP 6: Infection prevention & control and AMS – Email sent on 27/09/2021

STEP 7: TARGET antibiotic checklist audit – Email sent on 04/10/2021

STEP 8: Aspiration Payment Claim - Email sent on 05/10/2021

STEP 9: PCN Requirements and Flu - Email sent on 12/10/2021

STEP 10: Personalised asthma action plans (PAAPs) and promoting spacer device use in children prescribed pMDIs - email sent on 18/10/2021

STEP 11: Health Inequalities & COVID-19 Vaccination uptake – Email sent 26/10/2021

STEP 12: Weight Management Intervention & Referrals - Email sent 05/11/2021

STEP 13: Patient Safety - Email sent 09/11/2021

STEP 14: High Risk Medicines - Anticoagulant Audit - Email sent 16/11/2021

Next is:
STEP 15: Risk Review – GATEWAY CRITERIA

What you need to do:

1. Complete the following e-learning and e-assessments if not completed in previous years:
a). CPPE risk management
b). CPPE sepsis

2.   New risk review – management of minimise the risk of transmission for COVID-19.
          a).   Download the PharmaPlus pre-populated template and complete (See attached).
          b).   See each individual page to see if you are required to update these (based on whether you have completed the risk management domain in previous years).

As always, if you require any further support please contact the PharmaPlus team.

Regards,

PharmaPlus

Book Your TRAINING

Pre-Reg Training 2021

Pharma Plus Ltd.

Unit B1-B3, Livingstone Court, 55 Peel Road, Harrow, Middlesex HA37QT

info@pharmaplusltd.co.uk | Tel: 020 8863 3335 | Fax: 020 8863 4144 | www.pharmaplusltd.co.uk

Missed an email? Click here for an archive of our most recent communications!

NOTICE

The information contained in this electronic transmission is protected by privilege (which is not waived), strictly confidential and intended for use only by the addressee. If you receive this electronic transmission by mistake then the dissemination distribution or copying of it is strictly prohibited. In such a case please contact us immediately by telephone or return this electronic transmission.